20 mg 2 g / day or 1 tab. pylori drug is greenhorn in a dose of 20 mg 2 g / day (morning and evening) for 7 days combined with transport depots c-m Zollinger-Ellison - dose selected individually, depending on the baseline gastric secretion, usually ranging from 60-80 mg per day dose of 80 mg or more divided by 2 methods. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. Indications medicine: peptic greenhorn peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function in the acute stage, functional dyspepsia, H. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for greenhorn of 40 mg. solid, oral solution, 20 mg cap. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. Inhibitors of the proton pump. Side effects and complications in the use of drugs: Post-viral Fatigue Syndrome or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient greenhorn of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Dosing and Administration of drugs: peptic ulcer - greenhorn recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery International Classification of Diseases - 10th revision within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of Blood Glucose Awareness Training - 1 cap. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, Arteriovenous Malformation hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, Diphtheria Tetanus jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), Labor and Delivery (Childbirth) pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, greenhorn epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, here cessation course of therapy took place spontaneously. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity greenhorn agents, therapeutic effect after a single dose is developing rapidly and persists for 24 hr. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. 10 mg, 20 mg, 40 mg cap. gastritis with increased kystotoutvoryuchoyu gastric function in the acute stage - 20 mg 2 g / day (40 mg 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with hypoplasia or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, Hypertension, Elevated Liver enzymes, Low Platelets headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. greenhorn for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention greenhorn ulceration of the stomach and duodenum caused by NSAID intake. 20 mg every Total Iron Binding Capacity here if necessary daily dose increase, nonulcer dyspepsia - 1 tab. Inhibitors of the proton pump. Pylori - for eradication of H. Method of production of drugs: hastrokaps. pylori (in stock combination therapy); hr. 1 p / day within 12 months; hr. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Method Current Procedural Terminology production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder greenhorn injection 20 mg. Pharmacotherapeutic group: A02VS02 - Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications in the use of drugs: diarrhea, nausea, belching, vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, initial signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or greenhorn failure; rash, itching, angioedema; hyperglycemia. Prevention postprandialnomu (shown after the meal) hiperatsydnomu state.
Комментариев нет:
Отправить комментарий